Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview

Orthofix Medical

03/08/2026 13:45

Orthofix Medical Inc OFIX.OQ OFIX.O is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Lewisville Texas-based  company is expected to report a 3.0% increase in revenue to $209.277 million from $203.12 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Orthofix Medical Inc is for a loss of 41 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Orthofix Medical Inc is $16.00, about 35.6% above its last closing price of $11.80
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.68
-0.68
-0.13
Beat
80.9
Dec. 31 2026
-0.31
-0.31
-0.06
Beat
80.6
Sep. 30 2025
-0.33
-0.41
-0.57
Missed
-40.2​
Jun. 30 2025
-0.47
-0.49
-0.45
Beat
8.2
​​Mar. 31 2025
-0.26
-0.40
-0.08
Beat
79.8
Dec. 31 2024
-0.07
-0.05
0.02
Beat
140​
Sep. 30 2024
-0.12
-0.15
0.07
Beat
146.7
Jun. 30 2024
-0.21
-0.19
0.05
Beat
125.9
This summary was machine generated August 3 at 12:45 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)